Henry T. Lynch

Q: What Schools Are Affiliated With Henry T. Lynch

Henry T. Lynch is affiliated with the following schools: University of Cambridge, Medical University of Vienna, Institute of Cancer Research, University of Texas Medical Branch, University of Texas at Austin, Creighton University, University of Toronto, University of Oklahoma, University of Denver, Pomeranian Medical University in Szczecin

Henry T. Lynch's AcademicInfluence.com Rankings

Henry T. Lynch

Philosophy

#2206

World Rank

#3824

Historical Rank

#813

USA Rank

Logic

#492

World Rank

#910

Historical Rank

#195

USA Rank

philosophy Degrees

Download Badge

Philosophy

Henry T. Lynch's Degrees

Doctorate Medicine Creighton University

Why Is Henry T. Lynch Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Henry Thompson Lynch was an American physician noted for his discovery of familial susceptibility to certain kinds of cancer and his research into genetic links to cancer. He is sometimes described as "the father of hereditary cancer detection and prevention" or the "father of cancer genetics", although Lynch himself said that title should go to the early 20th century pathologist Aldred Scott Warthin.

(See a Problem?)

Henry T. Lynch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. (2004) (2947)
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. (1999) (2462)
Identification of the breast cancer susceptibility gene BRCA2 (1995) (2451)
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer (1993) (2347)
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) (1991) (2088)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. (2002) (1469)
Identification of the breast cancer susceptibility gene BRCA2 (1996) (1451)
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. (1997) (1157)
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. (2010) (1008)
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients (1996) (975)
Psychologic Aspects of Cancer Genetic Testing: A Research Update for Clinicians (1997) (943)
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. (1993) (911)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. (2004) (865)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial (2011) (826)
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. (1992) (810)
Hereditary colorectal cancer. (1991) (781)
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. (2006) (734)
Genetic susceptibility to non-polyposis colorectal cancer (1999) (682)
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. (1999) (676)
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. (1996) (673)
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. (1994) (667)
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. (2004) (624)
Alleles of the APC gene: An attenuated form of familial polyposis (1993) (617)
Genetic instability of microsatellites in endometrial carcinoma. (1993) (572)
Salpingo-Oophorectomy and the Risk Of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation (2006) (566)
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study (2000) (555)
The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome (2008) (551)
Milestones of Lynch syndrome: 1895–2015 (2015) (546)
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. (2008) (527)
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. (2015) (506)
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. (2014) (506)
Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review (1996) (500)
Extracolonic cancer in hereditary nonpolyposis colorectal cancer (1993) (495)
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. (2002) (488)
Familial gastric cancer: overview and guidelines for management* (1999) (483)
Hereditary factors in cancer. Study of two large midwestern kindreds. (1966) (480)
Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage (1996) (480)
Tumor‐infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma (2001) (473)
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. (2005) (456)
Hereditary Colorectal Cancer (1990) (450)
Colorectal cancer (2010) (437)
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer (2000) (430)
Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type (2014) (424)
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. (2007) (413)
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. (2005) (412)
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. (1994) (403)
Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia (2007) (391)
Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource (1985) (384)
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. (2002) (369)
Cancer family “G” revisited: 1895‐1970 (1971) (366)
Familial atypical multiple mole-melanoma syndrome. (1978) (348)
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability (2000) (346)
Gynecologic Cancer as a “Sentinel Cancer” for Women With Hereditary Nonpolyposis Colorectal Cancer Syndrome (2005) (344)
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. (2002) (340)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers (2008) (336)
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. (2006) (328)
GENETIC SUSCEPTIBILITY TO NONPOLYPOSIS COLORECTAL CANCER (1999) (323)
Advances in counselling and surveillance of patients at risk for pancreatic cancer (2007) (318)
Extracolonic cancer in hereditary nonpolyposis colorectal cancer. (1993) (307)
Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer (2004) (283)
The International Collaborative Group on HNPCC. (1994) (281)
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. (1996) (279)
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. (1998) (277)
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. (2007) (276)
E‐cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer (1999) (275)
Conversion of diploidy to haploidy (2000) (274)
Genetic testing in families with hereditary nonpolyposis colon cancer. (1999) (273)
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update (2006) (270)
Distinguishing right from left colon by the pattern of gene expression. (2003) (270)
Pathologic features of endometrial carcinoma associated with HNPCC (2006) (269)
Attenuated familial adenomatous polyposis (AFAP) a phenotypically and genotypically distinctive variant of FAP (1995) (266)
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations (2004) (261)
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. (2000) (261)
Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II. (1988) (257)
Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members (1998) (256)
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. (2011) (248)
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis (2014) (246)
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. (2007) (243)
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families (2002) (241)
Familial pancreatic cancer: a review. (1996) (240)
The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. (1981) (239)
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. (2008) (238)
The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. (2001) (236)
The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. (1994) (234)
An update of HNPCC (Lynch syndrome). (1997) (233)
A descriptive study of BRCA1 testing and reactions to disclosure of test results (1997) (231)
Gastric cancer: New genetic developments (2005) (230)
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. (2003) (226)
Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome) (1996) (225)
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus (1996) (222)
Curcumin: An age-old anti-inflammatory and anti-neoplastic agent (2016) (219)
Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. (2003) (218)
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study (2001) (216)
Pathology of hereditary non-polyposis colorectal cancer. (1994) (216)
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. (1998) (207)
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management (2007) (206)
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management (2009) (204)
Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. (1985) (201)
Prophylactic oophorectomy in inherited breast/ovarian cancer families. (1995) (200)
Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). (1987) (200)
Tritiated Thymidine (φp,φh) Labeling Distribution as a Marker for Hereditary Predisposition to Colon Cancer (1983) (196)
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (2010) (196)
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers (2008) (190)
A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. (1997) (188)
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers (2005) (183)
Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. (1999) (182)
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. (2008) (182)
Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management (2005) (178)
A polymorphic stop codon in BRCA2 (1996) (178)
Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications (2006) (177)
Risk modifiers in carriers of brca1 mutations (1995) (176)
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. (2008) (172)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2017) (171)
Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. (1990) (168)
GermlineSMAD4 orBMPRIA mutations and phenotype of juvenile polyposis (2002) (164)
Systemic cancer and the FAMMM syndrome. (1990) (160)
Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. (1992) (158)
Natural history of hereditary cancer of the breast and colon (1982) (158)
Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies (1985) (157)
Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome (1996) (155)
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. (1991) (155)
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. (2005) (151)
The tumor spectrum in HNPCC. (1994) (151)
Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma (1998) (148)
A genome wide linkage search for breast cancer susceptibility genes (2006) (146)
Hereditary diffuse gastric cancer (2002) (144)
Familial association of breast/ovarian carcinoma (1978) (143)
Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma (1978) (142)
Cancer risk in mismatch repair gene mutation carriers (2004) (142)
Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. (1995) (141)
Hereditary non-polyposis colorectal cancer (1991) (139)
Pancreatic Cancer Genetic Epidemiology Consortium (2006) (138)
Hereditary breast cancer. (1991) (138)
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. (2007) (138)
Muir‐Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome (1985) (135)
Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II) (1988) (135)
An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? (1999) (133)
Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. (1990) (131)
Hereditary Ovarian Cancer: A Clinicopathological Study (1992) (130)
Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline (2012) (130)
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. (2012) (129)
Mammary Gland Architecture as a Determining Factor in the Susceptibility of the Human Breast to Cancer (2001) (127)
Colorectal cancer in rural Nebraska. (1984) (127)
Hereditary diffuse gastric cancer: association with lobular breast cancer (2007) (127)
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC) (2005) (126)
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2005) (126)
Family history of colorectal cancer as a marker of potential malignancy within a screening program (1987) (126)
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinoma (2003) (125)
The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. (1994) (125)
The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. (1995) (124)
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study (2013) (124)
Pancreatic cancer and the FAMMM syndrome (2007) (123)
Role of heredity in multiple primary cancer (1977) (122)
Classification and risk assessment of individuals with familial polyposis, Gardner's syndrome, and familial non-polyposis colon cancer from [3H]thymidine labeling patterns in colonic epithelial cells. (1984) (121)
Seventh-Day Adventist vegetarians have a quiescent proliferative activity in colonic mucosa. (1985) (118)
Tumour spectrum in the FAMMM syndrome. (1981) (117)
Genetic predisposition to breast cancer (1984) (117)
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation. (2013) (117)
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. (1993) (116)
Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. (1996) (115)
Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? (1996) (115)
Flat adenomas in a colon cancer-prone kindred. (1988) (115)
A BRCA1 nonsense mutation causes exon skipping. (1998) (115)
Who should be sent for genetic testing in hereditary colorectal cancer syndromes? (2007) (114)
Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. (1996) (114)
Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II) (1988) (114)
Hereditary colorectal cancer. (1999) (114)
Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. (2010) (113)
Tumor variation in families with breast cancer. (1972) (113)
Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population (1998) (112)
Hereditary nonpolyposis colorectal cancer. (2000) (112)
Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. (1995) (112)
Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis. (1983) (111)
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2012) (111)
Paravertebral malignant rhabdoid tumor in infancy in vitro studies of a familial tumor (1983) (111)
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. (2005) (111)
The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer (2004) (110)
The influence of psychological distress on use of genetic testing for cancer risk (1997) (110)
Hereditary flat adenoma syndrome: A variant of familial adenomatous polyposis? (1992) (110)
Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms–mismatch repair (MAPP‐MMR) (2008) (110)
Pancreatic Cancer and the Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome (1991) (109)
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. (2003) (109)
Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007 (2008) (109)
Genetics and ovarian carcinoma. (1998) (109)
Cancer variation associated with the position of the mutation in the BRCA2 gene (2004) (108)
Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome (1994) (107)
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. (2006) (107)
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium (2002) (106)
Rectal cancer after prolonged sulindac chemoprevention. A case report (1995) (105)
Heredity and adenocarcinoma of the colon. (1967) (105)
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. (2015) (104)
Lynch syndrome: genetics, natural history, genetic counseling, and prevention. (2000) (104)
Multicenter Experience with Upper Gastrointestinal Polyps in Pediatric Patients with Familial Adenomatous Polyposis (2004) (103)
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers (2018) (103)
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. (2013) (103)
Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis. (1983) (103)
Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles (2013) (102)
Colorectal adenomas in the Lynch syndromes. Results of a colonoscopy screening program. (1990) (102)
Autonomy of the epithelial phenotype in human ovarian surface epithelium: Changes with neoplastic progression and with a family history of ovarian cancer (1996) (102)
Surveillance in hereditary nonpolyposis colorectal cancer: An international cooperative study of 165 families (1993) (102)
Parental communication of BRCA1/2 genetic test results to children. (2001) (102)
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. (2004) (101)
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (2011) (101)
Hereditary proximal colonic cancer (1977) (100)
BRCA1 and pancreatic cancer: pedigree findings and their causal relationships. (2005) (100)
MYC Is Amplified in BRCA1-Associated Breast Cancers (2004) (99)
Hereditary Pancreatic Cancer (2001) (99)
The Lynch syndrome II and urological malignancies. (1990) (99)
Lynch syndrome in the 21st century: clinical perspectives. (2016) (99)
Comparison of Extended Colectomy and Limited Resection in Patients With Lynch Syndrome (2010) (98)
Familial multiple myeloma: a family study and review of the literature. (2001) (97)
Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case–control study (2008) (97)
Cumulative incidence of colorectal and extracolonic cancers in mlh1 and msh2 mutation carriers of hereditary nonpolyposis colorectal cancer (2007) (97)
SELDI-TOF Serum Profiling for Prognostic and Diagnostic Classification of Breast Cancers (2004) (96)
The influence of psychological distress on use of genetic testing for cancer risk. (1997) (95)
Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome (2013) (94)
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2005) (93)
Hereditary Breast Cancer: Part I. Diagnosing Hereditary Breast Cancer Syndromes (2008) (93)
A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. (1994) (89)
Epidemiologic characteristics of the flat adenoma of muto (1992) (89)
Family history in an oncology clinic. Implications for cancer genetics. (1979) (89)
Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC‐like families: Problems in diagnosis, surveillance, and management (2004) (89)
Pathology and heredity of breast cancer in younger women. (1994) (89)
Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study (2002) (88)
Colon cancer genetics (1992) (87)
Brain tumors in individuals with familial adenomatous polyposis (2007) (87)
Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome (2004) (87)
Molecular pathology of primary and metastatic ductal pancreatic lesions (1997) (86)
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers (2011) (85)
NEW CUTANEOUS PHENOTYPE IN FAMILIAL MALIGNANT MELANOMA (1977) (85)
Heredity and malignant melanoma: implications for early cancer detection. (1968) (85)
Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. (2006) (84)
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. (2007) (83)
Carcinoma of the breast and ovary in three families. (1971) (83)
Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls. (1976) (82)
History and molecular genetics of Lynch syndrome in family G: a century later. (2005) (82)
Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). (2004) (81)
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers (2006) (80)
Genetics, biomarkers, and control of breast cancer: a review. (1984) (80)
The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation (2005) (80)
What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation (2012) (80)
A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. (2004) (79)
Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model (2009) (79)
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation (2019) (78)
The History of Lynch Syndrome (2013) (78)
“Organic brain syndrome” secondary to 5-fluorouracil toxicity (1981) (78)
An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. (1999) (77)
Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members. (1999) (76)
Hereditary cancer in adults. (1995) (76)
Surveillance and Management of Patients at High Genetic Risk for Ovarian Carcinoma (1982) (76)
The CYP1A2 Genotype Modifies the Association Between Coffee Consumption and Breast Cancer Risk Among BRCA1 Mutation Carriers (2007) (76)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers (2004) (76)
Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies (2003) (76)
The cancer syndrome: A status report (1981) (76)
New phenotypic aspects in a family with lynch syndrome II (1987) (75)
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers (2014) (75)
Surfaced-Enhanced Laser Desorption/Ionization Time-of-Flight (SELDI-TOF) Differentiation of Serum Protein Profiles of BRCA-1 and Sporadic Breast Cancer (2004) (75)
Genetics of Colonic Cancer (1998) (75)
Hereditary ovarian cancer. Heterogeneity in age at diagnosis (1991) (74)
Epidemiology of pancreatic cancer: an overview. (2003) (73)
Identifying hereditary nonpolyposis colorectal cancer. (1998) (73)
Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers (2001) (73)
Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? (1995) (73)
Allele increasing susceptibility to human breast cancer may be linked to the glutamate-pyruvate transaminase locus. (1980) (73)
Molecular Genetics and Clinical-Pathology Features of Hereditary Nonpolyposis Colorectal Carcinoma (Lynch Syndrome) (1998) (72)
Familial atypical multiple mole melanoma (FAMMM) syndrome: genetic heterogeneity and malignant melanoma. (1980) (72)
Upper urinary tract carcinoma in Lynch syndrome cases. (2011) (72)
Inherited genetic susceptibility to multiple myeloma (2014) (71)
Familial association of carcinoma of the breast and ovary. (1974) (69)
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy (2008) (67)
Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. (2013) (67)
Current Hypotheses on How Microsatellite Instability Leads to Enhanced Survival of Lynch Syndrome Patients (2010) (65)
Hereditary Factors in Carcinoma (1967) (65)
Phenotypic heterogeneity in multiple myeloma families. (2005) (65)
Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA1 or BRCA2 Mutations (2010) (65)
Familial ovarian carcinoma. Clinical nuances. (1986) (65)
Genomic Sequencing of DPC4 in the Analysis of Familial Pancreatic Carcinoma (1997) (65)
Inherited predisposition to cancer: A historical overview (2004) (64)
Family information service and hereditary cancer (2001) (64)
Segregation analysis of hereditary nonpolyposis colorectal cancer (1986) (64)
Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells. (1991) (64)
Primary choroidal and cutaneous melanomas, bilateral choroidal melanomas, and familial occurrence of melanomas. (1982) (64)
Adenocarcinoma of the small bowel in Lynch syndrome II (1989) (64)
Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) (2004) (64)
BRCA1 and BRCA2 hereditary breast carcinoma phenotypes (1997) (63)
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers (2010) (63)
A 10‐Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North‐American kindred (2002) (63)
Hereditary nonpolyposis colorectal cancer: preventive management. (2003) (63)
Screening adherence in BRCA1/2 families is associated with primary physicians' behavior (2004) (62)
Breast cancer genetics in an oncology clinic: 328 consecutive patients. (1986) (62)
Characterization of the neoplastic phenotype in the familial atypical multiple‐mole melanoma–pancreatic carcinoma syndrome (2003) (62)
ENDOMETRIAL CARCINOMA: MULTIPLE PRIMARY MALIGNANCIES, CONSTITUTIONAL FACTORS, AND HEREDITY (1966) (62)
Surveillance in Lynch syndrome: how aggressive? (1994) (62)
Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion (2011) (62)
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation (2013) (61)
Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. (2000) (61)
Genetics and smoking‐associated cancers. A study of 485 families (1986) (61)
In-situ breast cancer and BRCA 1 (1996) (61)
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2012) (60)
Frequency of hereditary nonpolyposis colorectal carcinoma (Lynch syndromes I and II). (1986) (60)
PMS2 monoallelic mutation carriers: the known unknown (2015) (58)
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. (2018) (58)
Familial cancer syndromes: A survey (1977) (58)
Classification of familial adenomatous polyposis: a diagnostic nightmare. (1998) (58)
Rectal cancer in FAP patient after sulindac (1994) (58)
Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications. (1997) (58)
Suspected hereditary nonpolyposis colorectal cancer (1999) (58)
Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines (1996) (58)
Familial Breast Cancer: Risk to the Contralateral Breast (1978) (58)
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers (2014) (58)
The cancer-family syndrome: A pragmatic basis for syndrome identification (1979) (57)
Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. (2012) (57)
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. (2011) (57)
Multiple primary cancers and prolonged survival: Familial colonic and endometrial cancers (1978) (57)
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells (2009) (56)
Oophorectomy after Menopause and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers (2012) (56)
Brca2 hereditary breast cancer pathophenotype (1997) (56)
Hereditary nonpolyposis colorectal cancer (HNPCC) (1999) (56)
Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study. (2008) (56)
Increasing incidence of breast cancer in family with BRCA1 mutation (1993) (56)
Phenotypic variation in colorectal adenoma/cancer expression in two families. Hereditary flat adenoma syndrome (1990) (55)
An update on Lynch syndrome. (1998) (55)
The cancer family syndrome and cancer control. (1971) (55)
Lynch Syndrome: History and Current Status (2004) (55)
Hereditary pancreatic adenocarcinoma. A clinical perspective. (2000) (54)
Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. (1990) (54)
Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer (2009) (54)
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers (2006) (54)
Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene. (1992) (54)
HEREDITY AND MULTIPLE PRIMARY MALIGNANT NEOPLASMS: SIX CANCER FAMILIES (1967) (54)
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study (2016) (54)
Genetic Epidemiology of Cancer (1989) (53)
The surgeon, genetics, and cancer control: the Cancer Family Syndrome. (1977) (53)
Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome). (2007) (53)
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers (2009) (53)
Alcohol and Tobacco Lower the Age of Presentation in Sporadic Pancreatic Cancer in a Dose-Dependent Manner: A Multicenter Study (2012) (53)
TGFBR1*6A may contribute to hereditary colorectal cancer. (2005) (52)
Klinefelter syndrome and cancer. A family study. (1974) (52)
Hereditary ovarian cancer: Heterogeneity in age at onset (2010) (52)
A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome. (1983) (52)
Ehlers-Danlos syndrome and "congenital" arteriovenous fistulae. A clinicopathologic study of a family. (1965) (50)
Genetics and Breast Cancer (1980) (50)
Management of hereditary site-specific colon cancer. (1977) (50)
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2007) (50)
Tumor variation in the cancer family syndrome: ovarian cancer. (1979) (49)
What the physician needs to know about Lynch syndrome: an update. (2005) (49)
Novel germline p16INK4 allele (Asp145Cys) in a family with multiple pancreatic carcinomas (1998) (49)
Expression of two mucin antigens in cultured human ovarian surface epithelium: Influence of a family hostory of ovarian cancer (1995) (49)
Smoking and the risk of breast cancer among carriers of BRCA mutations (2004) (49)
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers. (2014) (48)
Secondary male hypogonadism and congenital ichthyosis: association of two rare genetic diseases. (1960) (48)
Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population (1999) (48)
Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. (2018) (48)
Genetics and pancreatic cancer. (1994) (48)
Familial pancreatic carcinoma in Jews (2004) (47)
Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis. (1983) (47)
Familial mesothelioma: review and family study. (1985) (47)
Heredity and intraocular malignant melanoma: Study of two families and review of forty‐five cases (1968) (47)
Hereditary nonpolyposis colorectal cancer in a Navajo Indian family. (1985) (47)
Family studies of malignant melanoma and associated cancer. (1975) (47)
Oral Contraceptives and the Risk of Breast Cancer in BRCA 1 and BRCA 2 Mutation Carriers (2002) (47)
Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. (2003) (47)
Genetic factors in families with combined gastrointestinal and breast cancer. (1973) (46)
A Comparison of Bilateral Breast Cancers in BRCA Carriers (2005) (46)
Upper gastrointestinal manifestations in families with hereditary flat adenoma syndrome (1993) (46)
Hereditary ovarian and breast cancer: what have we learned? (2013) (46)
The genetic epidemiology of male breast carcinoma (1999) (45)
Prolonged survival as a component of a hereditary breast and nonpolyposis colon cancer. (1981) (44)
A century of progress in hereditary nonpolyposis colorectal cancer (lynch syndrome) (1999) (44)
Screening for familial and hereditary prostate cancer (2016) (44)
Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein. (2003) (44)
Hereditary cancer: Ascertainment and management (1979) (44)
Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature (2002) (44)
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. (2006) (44)
Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. (2015) (44)
Hereditary Factors in Adiposis Dolorosa (Dercum's Disease). (1963) (43)
Familial colon cancer in the Tel‐Aviv area and the influence of ethnic origin (1987) (43)
Failure to diagnose hereditary colorectal cancer and its medicolegal implications (1999) (43)
Plasma hormone profiles of young women at risk for familial breast cancer. (1978) (43)
The risk of breast cancer in women with a BRCA1 mutation from North America and Poland (2012) (43)
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. (1993) (43)
Xeroderma pigmentosum, malignant melanoma, and congenital ichthyosis. A family study. (1967) (43)
Familial Pancreatic Cancer: A Family Study (1992) (43)
Genetics and colon cancer. (1973) (42)
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer (1999) (42)
Abnormalities of lectin histochemistry in familial polyposis coli and hereditary nonpolyposis colorectal cancer (1990) (42)
Hereditary colorectal cancer-part II. (2005) (42)
Patent ductus arteriosus. Study of two families. (1965) (42)
Hereditary colon cancer syndromes. (1991) (41)
Laryngeal carcinoma in a lynch syndrome II kindred (1988) (41)
Cancer control in xeroderma pigmentosum. (1977) (41)
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration (2013) (41)
Association of soft tissue sarcoma, leukemia, and brain tumors in families affected with breast cancer. (1973) (40)
A familial aggregation of pancreatic cancer. An in vitro study. (1982) (40)
Rectal epithelial cell proliferation in a group of young adults. Influence of age and genetic risk for colon cancer (1988) (40)
Germline splicing mutations of CDKN2A predispose to melanoma (2003) (40)
Hereditary pancreatic cancer: a clinical perspective. (2009) (40)
Surveillance/management of an obligate gene carrier: the cancer family syndrome. (1983) (40)
Prevalence of Barrett Esophagus in First-Degree Relatives of Patients With Esophageal Adenocarcinoma (2011) (40)
Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. (1998) (40)
Origins and prevalence of the American Founder Mutation of MSH2. (2007) (39)
Early age of onset in familial breast cancer. Genetic and cancer control implications. (1976) (39)
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. (2009) (39)
Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. (2008) (39)
Hormone Therapy and the Risk of Breast Cancer in BRCA 1 Mutation Carriers (2008) (39)
Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer. (1995) (39)
Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Mutations in brief no. 148. Online. (1998) (39)
Familial pancreatic cancer (Part 1): Genetic pathology review. (1989) (39)
Breast cancer family history as a risk factor for early onset breast cancer (1988) (39)
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer (1999) (39)
Deletion (5q) in a desmoid tumor of a patient with Gardner's syndrome. (1994) (38)
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30 (2009) (38)
Analysis of CHEK2 gene for ovarian cancer susceptibility. (2004) (37)
CHEK2 mutation and hereditary breast cancer. (2006) (37)
Celecoxib Treatment Alters the Gene Expression Profile of Normal Colonic Mucosa (2006) (37)
The sarcoma, breast cancer, lung cancer, and adrenocortical carcinoma syndrome revisited. Childhood cancer. (1985) (37)
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers (2014) (37)
Low urinary estrogen glucuronides in women at risk for familial breast cancer. (1979) (37)
Tritiated thymidine (phi p, phi h) labeling distribution as a marker for hereditary predisposition to colon cancer. (1983) (37)
Prostate carcinoma and multiple primary malignancies: Study of a family and 109 consecutive prostate cancer patients (1966) (37)
AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study (2007) (37)
A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families. (2001) (36)
Genetic factors and colorectal cancer in Ashkenazi Jews (2004) (36)
Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer. (1996) (36)
Hereditary ovarian cancer. Pedigree studies, Part II. (1991) (36)
Communication of BRCA1/2 test results in hereditary breast cancer families (1999) (36)
Psychological aspects of monitoring high risk women for breast cancer (1994) (36)
Familial excess of cancer of the ovary and other anatomic sites. (1981) (36)
Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer (2003) (36)
Familial factors in bladder carcinoma. (1979) (36)
Colorectal cancer in hereditary breast cancer kindreds (1999) (36)
Hereditary colon cancer: Polyposis and nonpolyposis variants (1985) (36)
Genetics of Hodgkin's and non-Hodgkin's lymphoma: a review. (1992) (35)
Differential diagnosis of the cancer family syndrome. (1972) (35)
Histology of BRCA1-associated ovarian tumours (1994) (35)
Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families. (2000) (35)
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies (2007) (35)
The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. (2006) (35)
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. (2012) (34)
Tumor variation in three extended Lynch syndrome II kindreds. (1988) (34)
Familial breast cancer and its recognition in an oncology clinic (1981) (34)
The Lynch syndromes (1993) (34)
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update (2009) (33)
Organization of actin‐containing cables in cultured skin fibroblasts from individuals at high risk of colon cancer (1980) (33)
International Rates of Breast Reconstruction After Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers (2013) (33)
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? (2013) (33)
Molecular screening for the Lynch syndrome--better than family history? (2005) (33)
Clinical/genetic features in hereditary breast cancer (1990) (33)
Genetic counseling in a navajo hereditary nonpolyposis colorectal cancer kindred (1996) (33)
BRCA1 and BRCA2 families and the risk of skin cancer (2010) (33)
Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas (2007) (32)
Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. (1999) (32)
25 years of HNPCC. (1994) (32)
Cancer Genetics in the New Era of Molecular Biology (1997) (32)
Inherited, familial and sporadic primary open-angle glaucoma. (2007) (32)
Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. (2010) (31)
Familial risk and cancer control. (1976) (31)
The Muir-Torre syndrome in kindreds with hereditary nonpolyposis colorectal cancer (Lynch syndrome): A classic obligation in preventive medicine. (1999) (31)
Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability. (2009) (31)
Hereditary factors in pancreatic cancer. (2002) (31)
Genetic predictability in breast cancer risk. Surgical implications. (1971) (30)
Hereditary colon cancer--part I. (2005) (30)
Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking. (2006) (30)
Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus. (2016) (29)
Phenotypic variation in the familial atypical multiple mole-melanoma syndrome (FAMMM). (1983) (29)
Hereditary progressive atrioventricular conduction defect. (1975) (29)
Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. (2006) (29)
Hereditary ovarian carcinoma. Biomarker studies (1985) (29)
Automated detection of hereditary syndromes using data mining. (1997) (29)
Linkage analysis of chromosome 4 in families with familial pancreatic cancer (2007) (28)
Cancer in Jews: introduction and overview (2004) (28)
Colorectal cancer, survival advantage, and hereditary nonpolyposis colorectal carcinoma. (1996) (28)
Muir-Torre syndrome: Heterogeneity, natural history, diagnosis, and management (1993) (28)
The impact of genetic counseling upon the family milieu. (1963) (28)
Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM. (2011) (28)
Hereditary carcinoma of the ovary and associated cancers: a study of two families. (1990) (28)
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene (2005) (28)
Colorectal Cancer and the Muir-Torre Syndrome in a Gypsy Family: A Review (1999) (28)
Familial cancer in an oncology clinic (1981) (28)
Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer (1999) (27)
Hereditary breast cancer and family cancer syndromes (2004) (27)
Conversion of diploidy to haploidy - Individuals susceptible to multigene disorders may now be spotted more easily. (2000) (27)
Hereditary Breast Cancer: Practical Pursuit for Clinical Translation (2012) (27)
Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007 (2009) (27)
Recognition of the cancer family syndrome. (1983) (27)
Hl‐a in cancer family “n” (1975) (27)
Mutation of an mutL homologue in a Navajo family with hereditary nonpolyposis colorectal cancer. (1994) (27)
FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review (2010) (27)
SBLA syndrome revisited. (1990) (26)
Prognosis of BRCA1 hereditary breast cancer (1998) (26)
Strategies for Control (2017) (26)
The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study (2016) (26)
Genetic counseling for hereditary cancer. (1996) (26)
Variable gastrointestinal and urologic cancers in a lynch syndrome II kindred (1991) (26)
The Cancer-Family Syndrome (1979) (26)
The FAMMM Syndrome: Epidemiology and Surveillance Strategies (2000) (26)
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study (2015) (26)
Gynecologic cancer clues to Lynch syndrome II diagnosis: a family report. (1992) (25)
Familial cancer prevalence spanning eight years. Family N. (1974) (25)
Insurance adjudication favoring prophylactic surgery in hereditary breast-ovarian cancer syndrome. (1995) (25)
Can Unknown Predisposition in Familial Breast Cancer be Family‐Specific? (2013) (25)
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2018) (25)
Dynamic genetic counseling for clinicians (1969) (25)
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer (1999) (24)
Abnormal estrogen conjugation in women at risk for familial breast cancer at the periovulatory stage of the menstrual cycle. (1983) (24)
Hereditary atrial septal defect. Update of a large kindred. (1978) (24)
Familial occurrences of a variety of premalignant diseases and uncommon malignant neoplasms (1974) (24)
Hereditary Progressive Atrioventricular Conduction Defect: A New Syndrome? (1973) (24)
Sex hormone regulation of survivin gene expression. (2010) (24)
Germline RAP80 mutations and susceptibility to breast cancer (2008) (24)
Familial breast cancer in a normal population (1974) (24)
Cancer and the family history trail. (1991) (24)
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment (2017) (24)
Minimal genetic findings and their cancer control implications. A family with the cancer family syndrome. (1978) (24)
Torre's syndrome as phenotypic expression of cancer family syndrome. (1980) (23)
Genetics, Biomarkers, Hereditary Cancer Syndrome Diagnosis, Heterogeneity and Treatment: A Review (2014) (23)
Survival in hereditary breast and colon cancer. (1981) (23)
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study (2014) (23)
Predominance of brain tumors in an extended Li‐Fraumeni (SBLA) kindred, including a case of Sturge‐Weber syndrome (2000) (23)
Obstructive Lung Disease in Hereditary α1-Antitrypsin Deficiency (1970) (23)
Familial Adenomatous Polyposis and Extracolonic Cancer (2001) (23)
HNPCC (Lynch Syndrome): Differential Diagnosis, Molecular Genetics and Management - a Review (2003) (23)
Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge (2018) (23)
The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. (2006) (22)
The evolution of colorectal cancer genetics-Part 1: from discovery to practice. (2014) (22)
Histologic Features of Hereditary Nonpolyposis Colorectal Carcinoma (1990) (22)
Childhood cancer and the SBLA syndrome. (1979) (22)
Hereditary Breast Cancer: Part II. Management of Hereditary Breast Cancer: Implications of Molecular Genetics and Pathology (2008) (22)
BRCA1 and BRCA2 Mutations in Breast and Ovarian Cancer Syndrome: Reflection on the Creighton University Historical Series of High Risk Families (2005) (22)
Natural history and age at onset of hereditary breast cancer (1992) (21)
Prophylactic mastectomy: obstacles and benefits. (2001) (21)
Familial Hodgkin's disease and associated cancer. A Clinical‐Pathologic Study (1976) (21)
E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma. (2000) (21)
Management of familial breast cancer. II. Case reports, pedigrees, genetic counseling, and team concept. (1978) (21)
Genetics, etiology, and human cancer. (1980) (21)
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers (2018) (21)
Familial polyposis coli: heterogeneous polyp expression in 2 kindreds. (1979) (21)
The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. (2006) (21)
Hereditary Colorectal Cancer Review: Colonic Polyposis and Nonpolyposis Colonic Cancer (Lynch Syndrome I and II) (1984) (21)
Practical genetics of colorectal cancer. (2013) (21)
Reassignment of a cancer family syndrome gene to chromosome 18. (1988) (21)
Familial cancer: implications for surgical management of high-risk patients. (1978) (21)
Hereditary gastrointestinal cancer syndromes. (2011) (21)
Medical genetic study of eight pancreatic cancer-prone families. (1995) (20)
Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity (2016) (20)
Heredity and Gastrointestinal Tract Cancer (1978) (20)
Cancer of the colon: socioeconomic variables in a community. (1975) (20)
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer (2014) (20)
Integration of family history and medical management of patients with hereditary cancers (1999) (20)
AFAP: variety is the spice of life (1998) (20)
Familial bladder cancer in an oncology clinic. (1987) (20)
Hereditary cancer: family history, diagnosis, molecular genetics, ecogenetics, and management strategies. (2002) (20)
Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome (2007) (20)
Breast cancer, genetics, and age at first pregnancy. (1984) (20)
Leser-Trelat sign in mother and daughter with breast cancer. (1982) (20)
Management of familial breast cancer. I. Biostatistical-genetic aspects and their limitations as derived from a familial breast cancer resource. (1978) (20)
Skin, heredity, and cancer. (1978) (20)
A Founder Mutation of the MSH 2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States (2004) (19)
Programmed death 1 (PD-1) lymphocytes and ligand (PD-L1) in colorectal cancer and their relationship to microsatellite instability status. (2014) (19)
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer (2019) (19)
THE "WHOLE FAMILY" CONCEPT IN CLINICAL GENETICS. (1964) (19)
Hereditary ovarian cancer. Heterogeneity in age at diagnosis. (1991) (19)
Familial heterogeneity of colon cancer risk (1986) (19)
Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer (1997) (19)
Skin, heredity, and cancer (1969) (19)
Communication and technology in genetic counseling for familial cancer (2014) (19)
Genetic/epidemiological findings in a study of smoking-associated tumors. (1982) (19)
Spontaneous regression of metastatic malignant melanoma in 2 sibs with xeroderma pigmentosum. (1978) (19)
FAMILIAL COEXISTENCE OF DIABETES MELLITUS, HYPERLIPEMIA, SHORT STATURE, AND HYPOGONADISM (1966) (19)
Familial peritoneal ovarian carcinomatosis: a new clinical entity? (1986) (19)
Delay: a deterrent to cancer detection. (1968) (18)
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations. (2003) (18)
Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 Carriers (2011) (18)
Familial Adenomatous Polyposis in Children Younger than Age Ten Years: A Multidisciplinary Clinic Experience (2008) (18)
Xeroderma pigmentosum. Complementation group C and malignant melanoma. (1984) (18)
Clinical implications of advances in the molecular genetics of colorectal cancer. (1995) (18)
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers. (2005) (18)
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): a common genotype linked to oncogenes? (1985) (18)
Familial aggregation of carcinoma of the endometrium. (1994) (18)
Hereditary chronic lymphocytic leukemia: an extended family study and literature review. (2002) (18)
The cancer family syndrome: a status report. (1981) (17)
Delay factors in detection of cancer of the penis. (1969) (17)
Familial risk for neuroendocrine tumors (1993) (17)
Principles of Molecular Diagnostics and Personalized Cancer Medicine (2012) (17)
Diagnosing Lynch syndrome: is the answer in the mouth? (2003) (17)
Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis (2020) (17)
A follow-up study of colonic epithelial proliferation as a biomarker ina Native-American family with hereditary nonpolyposis colon cancer. (1991) (17)
Dermatoglyphic peculiarities in members of a high-cancer-risk kindred. (1974) (16)
Chromosome instability and the FAMMM syndrome. (1993) (16)
Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers (2011) (16)
Family History of Cancer (1995) (16)
Early age at breast cancer onset--a genetic and oncologic perspective. (1990) (16)
Immunology and the Lynch syndrome. (2008) (16)
National Institutes of Health consensus report on precursors to malignant melanoma. A difference in opinion. (1984) (16)
Multiple Primary Cancer, Including Transitional Cell Carcinoma of the Upper Uroepithelial Tract in a Multigeneration HNPCC Family: Molecular Genetic, Diagnostic, and Management Implications (2003) (16)
Malignant Congenital Osteopetrosis Resulting from a Consanguineous Marriage (1962) (16)
The Cutaneous Evolution of Nevi in a Patient with Familial, Atypical, Multiple‐mole Melanoma Syndrome (1985) (16)
American founder mutation for Lynch syndrome (2006) (16)
CONGENITAL HYPERTROPHY OF RETINAL PIGMENT EPITHELIUM IN NON-GARDNER'S POLYPOSIS KINDREDS (1987) (16)
Increased in vitro tetraploidy in dermal monolayer cultures derived from normals. (1983) (16)
Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer. (2006) (15)
Role of prophylactic colectomy in Lynch syndrome. (2003) (15)
A new approach to cancer screening and education. (1973) (15)
Genotype/phenotype of familial pancreatic cancer. (2006) (15)
A hMLH1 genomic mutation and associated novel mRNA defects in a hereditary non-polyposis colorectal cancer family. (2002) (15)
Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis (2008) (15)
Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in Argentina: Report from a Referral Hospital Register (2007) (15)
Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer. (1996) (15)
Muir-Torre syndrome and defective DNA mismatch repair genes. (1996) (15)
Desmoid tumors: genotype-phenotype differences in familial adenomatous polyposis--a nosological dilemma. (1996) (15)
Genetic heterogeneity and familial carcinoma of the breast. (1976) (15)
Major hereditary gastrointestinal cancer syndromes: a narrative review. (2017) (15)
Plasma lipids, lipoproteins, and familial breast cancer. (1995) (15)
Cancer risk assessment in a hereditary cancer prevention clinic and its first year's experience (1997) (15)
Heterogeneity and natural history of hereditary breast cancer. Surgical implications. (1990) (15)
Cancer genetics in women (1987) (14)
Genetic diagnosis of lynch syndrome II in an extended colorectal cancer‐prone family (1990) (14)
Phenotypic variation in hereditary adenomatosis: Unusual tumor spectrum (1982) (14)
Breast cancer genetics: family history, heterogeneity, molecular genetic diagnosis, and genetic counselling. (1996) (14)
Current status of prophylactic surgery for hereditary breast and gynecologic cancers (2001) (14)
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers. (2009) (14)
History of the International Collaborative Group on Hereditary NonPolyposis Colorectal Cancer (2005) (14)
Aldred scott warthin, m.d., ph.d. (1866‐1931) (1985) (14)
Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage. (2007) (14)
Cancer genes, multiple primary cancer, and von Hippel-Lindau disease. (1985) (14)
VITAMIN D-INTOXICATED PATIENT WITH HYPOPARATHYROIDISM; HYPERCALCEMIA, ACUTE CEREBELLAR ATAXIA, AND EEG CHANGES: MAGNESIUM SULFATE THERAPY. (1964) (14)
Altered transcriptome signature of phenotypically normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention (2013) (14)
Colorectal cancer in a nuclear family (1985) (13)
PSYCHODYNAMICS OF EARLY HEREDITARY DEATHS. ROLE OF THE MEDICAL GENETICS COUNSELOR. (1964) (13)
Hereditary malignant melanoma: a unifying etiologic hypothesis. (1986) (13)
Genetic Predisposition to Cancer (2003) (13)
The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. (1984) (13)
Excess of extracolonic non‐endometrial multiple primary cancers in MSH2 germline mutation carriers over MLH1 (2013) (13)
EPCAM deletions, Lynch syndrome, and cancer risk. (2011) (13)
Tumor infiltrating lymphocytes (TILs): Lessons learned in 30 years of study (2005) (13)
Inherited Susceptibility to Cancer: Clinical, Predictive and Ethical Perspectives (1999) (13)
The muir-torre syndrome: A variant of hereditary nonpolyposis colorectal cancer syndrome (1996) (13)
Making Sense of Missense in Lynch Syndrome: The Clinical Perspective (2010) (13)
Familial factors and genetic predisposition to cancer: population studies. (1991) (13)
"Cancer Families:" Adenocarcinomas (Endometrial and Colon Carcinoma) and Multiple Primary Malignant Neoplasms (1967) (13)
Cancer family history and genetic testing: are malpractice adjudications waiting to happen? (2002) (13)
Clinical, genetic, and biostatistical progress in the cancer family syndrome. (1979) (13)
Genetic counselling and hereditary breast/ ovarian cancer (1992) (13)
The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first‐degree relative with breast cancer (2018) (13)
Genetic counseling in hereditary nonpolyposis colorectal cancer: an extended family with MSH2 mutation. (1996) (13)
The CYP 1 A 2 Genotype Modifies the Association Between Coffee Consumption and Breast Cancer Risk Among BRCA 1 Mutation Carriers (2007) (12)
Morphological and morphometric measurements in colorectal mucosa of subjects at increased risk for colonic neoplasia. (1993) (12)
Heredity and Endometrial Carcinoma (1967) (12)
Hereditary nonpolyposis colorectal cancer (lynch syndrome II) in Uruguay (2000) (12)
Cancer-associated genodermatoses (2003) (12)
A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers. (2014) (12)
Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2015) (12)
Hereditary progressive atrioventricular conduction defect. A new syndrome? (1972) (12)
A family study of adenocarcinoma of the colon and multiple primary cancer. (1972) (12)
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry (2013) (12)
Aspirin Use is Associated with Lower Prostate Cancer Risk in Male Carriers of BRCA Mutations (2014) (12)
Breast cancer genetics and cancer control. Tumor association. (1975) (12)
Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers (2016) (12)
Cancer control problems in the lynch syndromes (1993) (12)
Wilms' tumor and congenital heart disease: report of a case and family. (1968) (12)
Genetic and immunopathological findings in a lymphoma family. (1989) (12)
Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control. (2007) (12)
Neuroendocrine-Type Prostatic Adenocarcinoma With Microsatellite Instability in a Patient With Lynch Syndrome (2010) (12)
Extremely early onset hereditary breast cancer (HBC): surveillance/management implications. (1988) (11)
Familial multiple myeloma. (2009) (11)
Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers (2018) (11)
Screening for GermLine Rearrangements and Regulatory Mutations in BRCA 1 Led to the Identification of Four New Deletions 1 (1999) (11)
Genetic counseling and HNPCC. (1994) (11)
Diethylstilbestrol, genetics, teratogenesis, and tumor spectrum in humans. (1985) (11)
Skin, heredity, and malignant neoplasms (1972) (11)
PCCR: Pancreatic Cancer Collaborative Registry (2011) (11)
Genome instability in blood cells of a BRCA1+ breast cancer family (2014) (11)
Subjective perspective of a family with Huntington's chorea. Implications for genetic counseling. (1972) (11)
International directory of genetic services. (1969) (11)
EARLY AGE OF ONSET AND FAMILIAL BREAST CANCER (1976) (11)
Gynecological malignancy as a "sentinel cancer" for women with HNPCC. (2001) (11)
Psychodynamics in a chronic debilitating hereditary disease. Myotonia dystrophica. (1966) (11)
Anticipation in familial Hodgkin's lymphoma (2000) (11)
Hereditary ovarian carcinoma. (1992) (11)
Familial breast cancer: risk to the contralateral breast. (1978) (11)
AURKA F 31 I Polymorphism and Breast Cancer Risk in BRCA 1 and BRCA 2 Mutation Carriers : A Consortium of Investigators of Modifiers of BRCA 1 / 2 Study (2007) (10)
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers. (2019) (10)
Genetic and communicable effects on carcinoembryonic antigen expressivity in the cancer family syndrome. (1978) (10)
Genetic predictability and minimal cancer clues in lynch syndrome II (1987) (10)
Genetics, natural history, surveillance, management, and gene mapping in the Lynch syndrome. (1995) (10)
Considerations for Comprehensive Assessment of Genetic Predisposition in Familial Breast Cancer (2015) (10)
Survey of cancer genetics (1997) (10)
Microsatellite instability, clinical implications, and new methodologies. (2000) (10)
Identification of high-risk pancreatic cancer-prone families. (2004) (10)
Epidemiology and Risk Factors (1989) (10)
Three new mutations in hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay. (2003) (10)
Genetic factors in breast cancer: a survey. (1976) (10)
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers (2019) (10)
Familial atypical multiple mole melanoma syndrome (FAMMM) (1983) (9)
Editorial: Serrated Polyposis: The Last (or Only the Latest?) Frontier of Familial Polyposis? (2012) (9)
Breast carcinoma and delay in treatment. (1969) (9)
Ophira M. GinsburgCharmaine Kim-SingWilliam D. Foulkes • Parviz GhadirianHenry T. LynchPing SunSteven A. Narod • Hereditary Breast Cancer Clinical Study Group (2010) (9)
Clinical results using informatics to evaluate hereditary cancer risk. (1995) (9)
The dermatologist, genetic counseling, and cancer-associated genodermatoses. (2000) (9)
Clinical nuances of Lynch syndromes I and II. (1988) (9)
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers. (2018) (9)
Dawning of the epigenetic era in hereditary cancer (2014) (9)
Hereditary diffuse gastric cancer: lifesaving total gastrectomy for CDH1 mutation carriers (2010) (9)
The surgeon and colorectal cancer genetics. Case identification, surveillance, and management strategies. (1990) (9)
Initial Report of a Family Registry of Multiple Myeloma (2009) (9)
A familial syndrome characterized by peculiar facies, small stature, chromosomal aberrations and aminoacriduria. (1974) (9)
Familial sarcoma: challenging pedigrees. (2003) (9)
Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review (1999) (9)
The family history and cancer control. Hereditary breast cancer. (1990) (9)
Carcinoembryonic antigen (CEA) in the cancer family syndrome (1978) (9)
Genetic counseling in an extended attenauted familial adenomatous polyposis kindred. (1996) (9)
Family Information Service Participation Increases the Rates of Mutation Testing Among Members of Families with BRCA1/2 Mutations (2009) (9)
Anthropometric Measures and Risk of Ovarian Cancer Among BRCA1 and BRCA2 Mutation Carriers (2012) (9)
Erratum: Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management (Cancer (2004) (100 (53-64)) (2004) (9)
Using data mining to characterize DNA mutations by patient clinical features (1997) (9)
The evolution of colorectal cancer genetics-Part 2: clinical implications and applications. (2014) (8)
Adenoma follow-up in at-risk Lynch syndrome family members. (1993) (8)
Genetic analysis of human breast cancer: Literature review and description of family data in workshop (1986) (8)
E2F-4 mutation in hereditary non-polyposis colorectal cancer. (2002) (8)
Endometrial Cancers in Mutation Carriers From Hereditary Breast Ovarian Cancer Syndrome Kindreds: Report From the Creighton University Hereditary Cancer Registry With Review of the Implications (2015) (8)
Multiphasic mobile cancer screening: A positive approach to early cancer detection and control (1972) (8)
Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers (2005) (8)
HNPCC-Lynch syndrome and idiopathic inflammatory bowel disease. A hypothesis on sharing of genes. (1997) (8)
Age-of-onset heterogeneity in hereditary breast cancer: Minimal clues for diagnosis (1988) (8)
13 – Genetic Counseling and Cancer1 (1979) (8)
Colorectal cancer: Update on the clinical management of Lynch syndrome (2013) (8)
Phase II breast cancer chemoprevention trial of the third generation selective estrogen receptor modulator arzoxifene. (2006) (8)
Hereditary carcinoma of the ovary and associated cancers: A study of two families (1990) (8)
Familial adenomatous polyposis (1997) (8)
Familial prostate cancer and HOXB13 founder mutations: geographic and racial/ethnic variations (2012) (8)
FAMILY CENTERED GENETIC COUNSELING: ROLE OF THE PHYSICIAN AND THE MEDICAL GENETICS CLINIC. (1965) (8)
Population differences in familial adenomatous polyposis may be an expression of geographic differences in APC mutation pattern. (2007) (8)
Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature. (2019) (8)
Cancer concordance and the hypothesis of autosomal dominant transmission of cancer diathesis in a remarkable kindred. (1974) (8)
The clinical use of genealogical techniques in cancer investigations: a questionnaire survey. (1993) (8)
Diagnosis and management issues in pediatric patients with gastrointestinal polyps (2003) (8)
Analysis of the CDKN2A Gene in FAMMM Syndrome Families Reveals Early Age of Onset for Additional Syndromic Cancers. (2019) (8)
Barrett’s esophagus in the patients with familial adenomatous polyposis (2014) (8)
Genetic counseling and cancer: implications for cancer control. (1968) (7)
Modification of BRCA 1-Associated Breast and Ovarian Cancer Risk by BRCA 1-Interacting Genes (2011) (7)
Modification of BRCA 1-and BRCA 2-associated Breast Cancer Risk by AIB 1 Genotype and Reproductive History 1 (2001) (7)
The identification and management of hereditary diffuse gastric cancer in a large Jordanian family (2011) (7)
A note on "cancer-susceptible" and "cancer-resistant" genotypes: implications for cancer detection and research. (1966) (7)
Familial sarcoma (2003) (7)
Cancer, heredity and genetic counseling. Xeroderma pigmentosum (1967) (7)
Familial and Genetic Factors — New Evidence (1989) (7)
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome (2019) (7)
BRCA1, pathology, and survival. (1998) (7)
Identification of an HNPCC family. (1994) (7)
Detecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers. (2009) (7)
What is hereditary colon cancer? (1983) (7)
Sessile Serrated Adenomas: Why Conventional Endoscopy Is Okay for Unconventional Polyps (2014) (7)
SKIN CANCER DEVELOPING IN XERODERMA PIGMENTOSUM PATIENT RELAXING SUNLIGHT AVOIDANCE (1981) (7)
Genetic counseling in cleft lip and cleft palate. (1981) (7)
Lynch syndrome in South America: past, present and future (2016) (7)
Natural history of at-risk Lynch syndrome family members with respect to adenomas. (1992) (7)
Molecular Analysis of the Retinoblastoma (Rb) Gene in Human Colorectal Carcinomas (1990) (7)
Recent Progress in the Genetic Epidemiology of Cancer (1991) (7)
Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer. (2004) (7)
Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? (2015) (7)
Genetic counseling and the physician. (1970) (7)
Etiology of carcinoma: genetic determinism. (1966) (7)
FAMILIAL INDICATIONS FOR PROPHYLACTIC SURGERY IN BREAST-CANCER-PRONE FAMILIES (1978) (7)
Sex differences in lung cancer incidence: a genetic model. (1981) (7)
Genetic factors in carcinoma. (1969) (7)
A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families (2017) (7)
Cancer genetic problems: host-environmental considerations. (1974) (7)
Family with acute myelocytic leukemia, breast, ovarian, and gastrointestinal cancer. (2002) (6)
Genetic Variation in IGF 2 and HTRA 1 and Breast Cancer Risk among BRCA 1 and BRCA 2 Carriers (2011) (6)
History of the International Collaborative Group on Hereditary NonPolyposis Colorectal Cancer (2005) (6)
Flat cancers do develop in the polyp-free large intestine (1997) (6)
Tetralogy of Fallot in two siblings. Associated anomalies of the head and neck in one child. (1966) (6)
Esophageal cancer in a midwestern community. (1971) (6)
Genetics in urogenital cancer. (1980) (6)
Clinical selection of candidates for mutational testing for cancer susceptibility. (2006) (6)
Effect of the third generation selective estrogen receptor modulator arzoxifene on mammographic breast density. (2006) (6)
[Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]. (2007) (6)
Commentary on Almassalha et al., "The Greater Genomic Landscape: The Heterogeneous Evolution of Cancer". (2016) (6)
Hereditary gynecologic cancer. (1998) (6)
Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA 1 or BRCA 2 Mutations (2009) (6)
Survival data from a multiphasic mobile cancer detection unit. (1976) (6)
Biomarkers, genetics and cancer (1985) (6)
Glioblastoma multiforme as initial internal malignancy in Muir-Torre syndrome (MTS) (2015) (6)
Hereditary nonpolyposis colon cancer: (Lynch syndrome I and II). A challenge for the clinician. (1989) (6)
Klippel-Feil syndrome and bicuspid aortic valve: report of a case. (1966) (6)
Cancer in the Third World: Bangladesh 1980. (1981) (6)
alpha-L-fucosidase variant and lipid-associated sialic acid in hereditary ovarian cancer. (1987) (6)
Low serum IgA in a familial ovarian cancer aggregate. (1982) (6)
PROXIMAL COLON CANCER IN FAMILIAL CARCINOMA OF THE COLON EXCLUSIVE OF FAMILIAL POLYPOSIS COLI (1977) (6)
[Prevention of colorectal carcinoma. Current WHO guidelines for early detection of colorectal carcinoma. World Health Organization Collaborating Center for the Prevention of Colorectal Cancer]. (1996) (6)
Familial hepatocellular carcinoma in an endemic area of Thailand. (1984) (6)
Psychodynamics in cancer detection: a patient with advanced cancer of the lip. (1966) (6)
Heredity and breast cancer: implications for cancer control. (1966) (6)
Breast cancer diagnosis in a putative obligate gene carrier. A family study. (1988) (5)
The colonoscopist and the Lynch syndromes. (1990) (5)
Attitudes and delay in cancer detection (1968) (5)
The surgeon, genetics, and malignant melanoma. (1992) (5)
Monitoring High Risk Women: Psychological Aspects (1991) (5)
Stemming the tide of cancer for BRCA1/2 mutation carriers. (2008) (5)
Endocrine profile in a patient with familial breast cancer. A case‐control study (1979) (5)
The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. (2014) (5)
Genetic Counseling and the Advanced Practice Oncology Nursing Role in a Hereditary Cancer Prevention Clinic: Hereditary Breast Cancer Focus (Part I) (2009) (5)
Surgical Strategies for Management of the Lynch Syndromes (1990) (5)
Hormone replacement therapy and the risk of ovarian cancer in BRCA 1 and BRCA 2 mutation carriers (2005) (5)
Heredity and colon cancer. (1975) (5)
Genetic counseling, familial breast cancer, and the surgeon's responsibility. (1980) (5)
Colorectal cancer survival advantage in MUTYH-associated polyposis and Lynch syndrome families. (2010) (5)
Genetics and smoking-associated cancers: 461 families (1985) (5)
Familial polyposis coli and neurofibromatosis in the same patient: a family study. (1987) (5)
Cancer occurrence during follow-up of the CAPP2 study -aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to several years after completion of therapy (2010) (5)
Challenging pancreatic cancer-prone pedigrees: a nosologic dilemma (2002) (5)
Efficacy of proximal colectomy for surgical management of right-sided first colorectal cancer in Lynch Syndrome mutation carriers. (2018) (5)
Pathology and genetic markers of colorectal cancer in Lynch syndromes I and II (1988) (5)
A hereditary cancer consultation clinic. (1989) (5)
Genetics and Colorectal Cancer1 (1985) (4)
Genetic risk in ovarian cancer. (1992) (4)
The Relevance of the Family History of Cancer in a Screening Program for Large Bowel Tumors (1986) (4)
In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigrees (2020) (4)
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (2012) (4)
Surveillance and management of hereditary breast cancer (1981) (4)
CEA and genetics (1983) (4)
Familial Pancreatic Cancer (2010) (4)
NAMING THE MELANOMA-PRONE SYNDROME (1981) (4)
Small, nonpolupoid colonic neoplasms (1990) (4)
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers? (2020) (4)
Genetics of rectal cancer. (1984) (4)
Recent progress in colorectal cancer : biology and management of high risk groups : proceedings of the 5th International Symposium on Colorectal Cancer : biology and management of high risk groups, Torino, 24-26 September 1991 (1992) (4)
Screening for hereditary colorectal cancer (1994) (4)
Cancer Frequency Variations Among and Within Families (1972) (4)
Colonoscopy in relation to the evolving genetics of familial colorectal cancer. (1995) (4)
Update on familial pancreatic cancer (2001) (4)
Common BRCA 2 Variants and Modification of Breast and Ovarian Cancer Risk in BRCA 1 Mutation Carriers (2005) (4)
Genetic Counseling and Management of Newly Diagnosed Breast Cancer Patients at Genetic Risk for BRCA Germline Mutations (2006) (4)
Is there a genetic predisposition to malignant mesothelioma (1994) (4)
Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus. (2016) (4)
A questionnaire survey of Midwest dermatologists on the clinical-genetic aspects of patients with multiple atypical nevi. (1993) (4)
Laterality of breast cancer in families. (1979) (4)
Hereditary factors in childhood cancer. (1982) (4)
FAMILIAL SUSCEPTIBILITY TO LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (1977) (4)
Erratum: Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus (American Journal of Human Genetics (2016) 98(6) (1082–1091) (S000292971630057X) (10.1016/j.ajhg.2016.03.022)) (2016) (4)
Multiple HNPCC tumours: ask the family! (1998) (4)
Cellular immune function study in an ovarian cancer-prone kindred. (1982) (4)
Diethylstilbestrol, teratogenesis, and carcinogenesis: medical/legal implications of its long-term sequelae, including third generation effects. (1990) (4)
Conceptual differences on the occurrence of internal malignancies in the FAMMM syndrome. (1994) (4)
Mutations in BRCA 1 and BRCA 2 in Breast Cancer Families : Are There More Breast Cancer-Susceptibility Genes ? (2006) (4)
HEREDITY AND THE MORE COMMON MALIGNANCIES OF MAN: CARCINOMA OF THE BREAST, STOMACH, COLON, LUNG, PROSTATE, AND ENDOMETRIUM (1967) (4)
Hereditary diffuse gastric cancer: Natural history, pathology, screening limitations, and prophylactic total gastrectomy in CDH1 mutation carriers (2007) (4)
Clues to cancer risk: biologic markers. (1975) (4)
Challenging colonic polyposis pedigrees: differential diagnosis, surveillance, and management concerns. (2004) (4)
Genetic counseling issues (1997) (4)
The NIH Consensus Report on "Precursors to Malignant Melanoma". A different perspective. (1984) (4)
Familial Cancer. Foreword. (2008) (4)
Cigarette Smoking and Breast Cancer Risk (2011) (4)
A computer based system of coding for genetic studies of large kindreds. (1970) (3)
Therapeutic biomarker differences between MSI-H and MSS colorectal cancers. (2015) (3)
Family information service (FIS) in a BRCA1 extended family. (2006) (3)
Familial Cancer: Editorial (2001) (3)
Pros and cons of genetic screening for breast cancer. (1999) (3)
For the Record: The History of Precursors to Malignant Melanoma-Reply (1984) (3)
RESPONSE: Re: Familial Multiple Myeloma: a Family Study and Review of the Literature (2002) (3)
Genetics, skin and cancer control. (1971) (3)
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry (2013) (3)
Heredity, emotions and cancer control. (1968) (3)
Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers (2005) (3)
Genetic counseling of high-cancer-risk patients: jurisprudential considerations. (1978) (3)
Medical-legal aspects of familial cancer. (1976) (3)
Bio-assay of Human Serum Parathormone-like Activity. (1964) (3)
Genetics of Common Tumors (1991) (3)
Regression of colorectal adenomas with intravenous cytotoxic chemotherapy in a patient with familial adenomatous polyposis. (2004) (3)
Hepatic artery infusion: surgical approach. (1984) (3)
Obstructive lung disease in hereditary alpha 1-antitrypsin deficiency. (1970) (3)
Psycho-social factors in a family with a disfiguring genetic fault. (1965) (3)
Hereditary Colon Cancer Syndromes and Their Surveillance/Management1 (1986) (3)
Cancer in southeast Asia. Strategies for control. (1984) (3)
Serum and hair selenium levels in hereditary nonpolyposis colorectal cancer (1984) (3)
Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes. (1996) (3)
Genetic Counseling and the Advanced Practice Oncology Nursing Role in a Hereditary Cancer Prevention Clinic: Hereditary Breast Cancer Focus (Part II) (2009) (3)
Hereditary pancreatic cancer: Pedigree analysis of pancreatic cancer families (1994) (3)
Genetics and environment in Hodgkin's disease (1995) (3)
HLA in breast cancer-prone families and the cancer family syndrome. (1977) (3)
Genetic Epidemiology and the Familial Atypical Multiple Mole Melanoma Syndrome (1991) (3)
Familial neuroendocrine tumors as a model of hereditary cancer. (1997) (3)
Foreword for “100 years of Lynch syndrome” (2013) (3)
Phenotypic Variation and Systemic Cancer in the FAMMM Syndrome (1988) (3)
BRCA1 and BRCA2: to test or not to test (2001) (3)
Cancer prevention, molecular genetics and hereditary cancer syndromes of colon and breast. (1996) (3)
Microsatellite instability, disease-free survival and role of tumour infiltrating lymphocytes (Invited editorial on 'Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicenter study'). (2015) (3)
Historical Aspects of Lynch Syndrome (2010) (3)
Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia family. (2008) (3)
Colorectal Cancer: Molecular and Cellular Abnormalities (2002) (3)
Is cancer communicable? (1984) (3)
Prevalence of extra-esophageal cancers in patients with Barrett's esophagus and esophageal adenocarcinoma. (2012) (2)
Challenging pedigrees seen in a hereditary cancer consultation center. (2004) (2)
Glossary of key terms. (1996) (2)
HEREDITY AND CARCINOMA (1968) (2)
Familial Clustering of Plasma Carcinoembryonic Antigen (CEA) in the Cancer Family Syndrome (1978) (2)
Heredity and colon cancer. Part VII. Prognosis in hereditary colon cancer. (1975) (2)
Hereditary colon cancer syndromes: polyposis and nonpolyposis (Lynch syndromes I & II) variants (1987) (2)
A Comparison of Statistical Approaches for Genetic Anticipation with Application to Pancreatic Cancer (2007) (2)
Familial polyposis coli: genetics, surveillance, and treatment. (1988) (2)
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers (2007) (2)
Lynch Syndrome: Its Phenotypic and Genotypic Heterogeneity (2011) (2)
GENETIC TESTING OF FAMILIES WITH HEREDITARY DISEASES. AUTHORS' REPLY (1996) (2)
PALATAL ABNORMALITIES IN HEREDITARY DISEASES. (1965) (2)
Total colectomy and the cancer family syndrome (1982) (2)
Variation in cancer risk among families with genetic susceptibility (2020) (2)
Genetic counseling in cancer: a status report--part 2. (1996) (2)
Cancer variation associated with the position of BRCA2 gene mutation (2003) (2)
Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer (2015) (2)
The role of genetics and host factors in cancer susceptibility and cancer resistance (1976) (2)
Cigarette Smoking and Breast Cancer Risk: Limited Evidence of Genotypic and Exogenous Carcinogenic Factors and Their Interactions (2010) (2)
Increased expression of SV40 T antigen and cell division in skin fibroblast cell lines derived from a family at high risk of carcinoma (Family G of warthin) (2004) (2)
Familial Carcinoma of Unknown Primary. (2016) (2)
HEREDITY AND CARCINOMA (1968) (2)
Should Risk-Reducing Surgery in Women from Hereditary Breast Ovarian Cancer Families be Confined to Removal of the Fallopian Tubes with Ovarian Conservation? (2015) (2)
Malignant Melanoma and Associated Cancer (1976) (2)
Lynch syndrome TACSTD1 family with predominant colorectal cancer. (2010) (2)
Melanoma and the atypical nevus. (1987) (2)
Introduction to special issue of Familial Cancer (2016) (2)
Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation (2020) (2)
Familial pancreatic cancer (Part II): Surveillance, diagnostic tests, and surgical strategies. (1990) (2)
Lynch Syndrome II in a Navajo Family: A Revisit (2007) (2)
Concurrent Von Recklinghausen's neurofibromatosis, hereditary spherocytosis and fronto nasal dysplasia. (1982) (2)
Familial Atrioventricular Conduction Defect (1973) (2)
570PTHYMIDYLATE SYNTHASE OVER-EXPRESSION UNDERLIES THE OBSERVED LACK OF 5-FU THERAPY BENEFIT FOR MSI-H COLORECTAL CANCERS. (2014) (2)
The explosion of hereditary cancer knowledge: Benefiting from a family information service (2007) (2)
Inactivation of E-cadherin in stomach cancers arising in the hereditary diffuse gastric cancer syndrome (2000) (2)
Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer. (2004) (2)
The benefits of a model of interval comprehensive assessments (MICA) in hereditary cancer Syndromes: Hereditary diffuse gastric cancer (HDGC) as an example. (2019) (2)
The delay problem in cancer. (1972) (2)
Mammography Screening in Women Under Age 50 Years (1988) (2)
A demonstration project on cancer screening in rural Thailand: preliminary report. (1985) (2)
The role of Creighton University’s hereditary cancer center (2015) (2)
The familial atypical multiple-mole melanoma syndrome and its associated risk for pancreatic cancer (1994) (2)
Overview and Epilogue (1990) (2)
Hereditary colorectal cancer : proceedings of the Fourth International Symposium on Colorectal Cancer (ISCC-4), November 9-11, 1989, Kobe Japan (1990) (2)
Cancer resistance: I. (1974) (2)
BRCA 1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA 1 GermLine Mutations 1 (2003) (2)
Historical and Natural Cancer History Facets of the Lynch Syndromes (1990) (2)
Dysplastic nevus syndrome. (1986) (1)
Endometrial and ovarian cancer risk-reducing surgery in women with lynch syndrome (2008) (1)
Consideration of privacy and confidentiality in conducting family studies (1976) (1)
Host factors in cancer prevention (1979) (1)
Familial embryonal carcinoma in a cancer-prone kindred. (1985) (1)
Delay: a problem in cancer control. (1970) (1)
What can be done to Improve Uptake of Genetic Testing for Inherited Colorectal Cancer Susceptibility (2013) (1)
Hereditary breast cancer: Search for biomarkers (1987) (1)
Heredity, cancer, and the genetics clinic. (1967) (1)
Hereditary malignant melanoma--conceptual differences. (1985) (1)
Genetic Basis of Cancer Syndromes (2003) (1)
Null Results in Brief Common Genetic Variation at BARD 1 Is Not Associated with Breast Cancer Risk in BRCA 1 or BRCA 2 Mutation Carriers (2011) (1)
Genetic Testing of Families With Hereditary Diseases-Reply (1996) (1)
Commentary on Lynch syndrome and related familial colorectal cancers (2008) (1)
A medical and genetic critique of the familial atypical multiple mole melanoma syndrome and the dysplastic nevus syndrome. (1985) (1)
Familial plasma cell disorders and associated cancers. (2011) (1)
Genetic aetiology of diffuse gastric cancer: so near, yet so far (2004) (1)
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer (2019) (1)
Heredity and cancer. (1969) (1)
Kluwer Academic PublishersFamilial Cancer (2001) (1)
GENETIC ANTICIPATION IN PANCREATIC CANCER: COMPARISON OF STATISTICAL TESTS (2006) (1)
Breast cancer and the use of oral contraceptives. (1986) (1)
Small, nonpolypoid colonic neoplasms. (1990) (1)
Genetic susceptibility testing (1997) (1)
Genetics of Colorectal Cancer (1999) (1)
A note on cancer control. (1971) (1)
Cancer families, a hereditary cancer syndrome. (1968) (1)
Compliance by High-Risk Women (1995) (1)
Breast Cancer Genetics1 (1985) (1)
Genome instability in blood cells of a BRCA1 + breast cancer family (2014) (1)
A Study of Five Cancer Families. (1966) (1)
Novel MSH2 Mutation in the First Report of a Vietnamese–American Kindred with Lynch Syndrome (2015) (1)
Hereditary Factors in Endometrial Cancer (2007) (1)
The impact of family information services on genetic testing uptake among relatives in Lynch syndrome families. (2013) (1)
The Familial Atypical Multiple Mole Melanoma Syndrome and Visceral Cancer (1990) (1)
MEDICAL GENETICS IN NEBRASKA. (1964) (1)
P1039 HEREDITARY MIXED POLYPOSIS SYNDROME MAY BE ASSOCIATED WITH MUTATION IN THE BMPR1A GENE ON CHROMOSOME 10Q22.3 (2004) (1)
Biomarker studies in hereditary ovarian carcinoma. (1985) (1)
Mendelian Predisposition to Lymphomagenesis (1984) (1)
Video Capsule Endoscopy: What Is the Role in Surveillance of Hereditary Colon Cancer Syndromes? (2006) (1)
Change in serum dehydroepiandrosterone, testosterone, insulin-like growth factor-1, and osteocalcin levels with the third generation selective estrogen receptor modulator arzoxifene (LY353381·HCI) (2001) (1)
Therapeutic and Preventive Implications of Moonshot in Hereditary Cancer Syndromes. (2017) (1)
FAMILIAL ADENOMATOUS POLYPOSIS IN CHILDREN UNDER 10; PRESENTATION AND CLINICAL OUTCOME: WHO GOES TO COLECTOMY?: 136 (2005) (1)
Weight Gain After Oophorectomy Among Women with a BRCA1 or BRCA2 Mutation (2015) (1)
Phenotypic variation in hereditary breast cancer. Cancer control implications. (1994) (1)
Heredity and colon cancer. (1975) (1)
Familial aggregation of lung cancer and other pulmonary diseases (1976) (1)
Breast Cancer Genetics: Syndromes, Genes, Pathology, Counseling, Testing, and Treatment (2009) (1)
Clinical Importance of Familial Cancer1 (1985) (1)
Abstracts Accepted for Plenary & Parallel Sessions 55th Annual Cancer Symposium Society of Surgical Oncology March 14–17, 2002 Denver, CO (2007) (1)
Medical students as "probation officers" for juvenile offenders. (1971) (1)
Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation (2020) (1)
P0787 SAFETY AND EFFICACY OF CELECOXIB IN CHILDREN WITH FAMILIAL ADENOMATOUS POLYPOSIS (2004) (1)
Klinefelter's syndrome and metastatic breast cancer (1985) (1)
The American founder mutation for Lynch syndrome: Prevalence and cancer control implications (2005) (1)
Lay Volunteers and Mobile Multiphasic Cancer Screening (1974) (1)
Investigational strategies for detection and intervention in early-stage pancreatic cancer (1994) (1)
Gene-environment interactions in hereditary nonpolyposis colorectal cancer: potentiation of colon cancer risk by tobacco use and HMLH-1 mutations (2003) (1)
Diagnosing lynch syndrome in absence of colorectal cancer. (2012) (1)
COMPLETE TRANSPOSITION OF GREAT VESSELS. MANIFESTATION IN TWO SIBLINGS CONFIRMED AT AUTOPSY. (1964) (1)
Familial Heterogeneity of Breast Cancer Risk (1986) (1)
Colorectal Cancer in Rural Nebraska 1 (2006) (1)
A Founder Mutation of theMSH2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States (2004) (1)
Cancer genetics, genetic counseling, and cancer control. (1975) (1)
DOES GEOGRAPHIC VARIATION IN THE DISTRIBUTION OF APC GENE MUTATION ACCOUNT FOR PHENOTYPIC VARIATION IN FAMILIAL ADENOMATOUS POLYPOSIS?: 134 (2005) (1)
MGUS, multiple myeloma, and paratarg-7. (2009) (1)
Atypical nevi and melanoma update at American Academy of Dermatology meeting, December 1986. (1987) (1)
Cancer genetics: surveillance and control. (1987) (1)
How early to test for a cancer-causing germline mutation. (2008) (1)
Cancer and Genetic Counseling (1967) (1)
Title: Lynch Syndrome in the 21 st Century: Clinical Perspectives (2015) (1)
Involuntary Hospitalization And Bias Against Marginalized Groups (2019) (1)
Immunochemical Biological Markers and Hereditary Cancer Risk (1978) (1)
A novel mutation in hMLH1 gene in a Uruguayan Hereditary non-polyposis colorectal cancer (HNPCC-Lynch syndrome) family. (2008) (0)
Heredity and Malignancies of The Reticuloendothelial System (1967) (0)
THE LYNCH SYNDROME: NATURAL HISTORY WITH SURVEILLANCE AND MANAGEMENT IMPLICATIONS (1993) (0)
Phenotypic Variation in Hereditary Breast Cancer (2017) (0)
Letter: Malignant melanoma and associated cancer. (1976) (0)
Wilms' Tumor, Congenital Heart Defects, Pheochromocytomas and Thyroid Cancer-Reply (1968) (0)
Hereditary Malignant Melanoma and the Fammm Syndrome (2019) (0)
Cancer genetics in women. Volume I (1987) (0)
Teaching comprehensive medicine in the home setting: a preliminary report. II. (1969) (0)
Conclusions — Future Directions (2003) (0)
Where R.N.s run a mobile cancer-detection unit. (1974) (0)
Extracolonic Manifestations of Familial Adenomatous Polyposis After Proctocolectomy—Invited Critique (2005) (0)
Creighton University to open hereditary cancer prevention clinic. (1995) (0)
Helicobacter pylori and Gastroduodenal Secretory Function (1996) (0)
letter to the editor (1999) (0)
First report of a family with Lynch syndrome type II in Puerto Rico. (2001) (0)
INTROGENIC HYPOTHYROIDISM IN A PATIENT WITH TURNER'S SYNDROME (1965) (0)
Acquired nonfamilial melanoma: an inappropriate conclusion. (1987) (0)
Lifetime Polyp Rate Comparisons and the EPCAM Deletion (2015) (0)
Contributors (2012) (0)
Proteomic analysis of BRCA-1 breast cancer, BRCA-1 carriers and sporadic breast cancer (2004) (0)
Lynch Syndrome and the Role of the Registered Nurse: Commentary on “Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses” (2008) (0)
PAST, PRESENT, AND FUTURE OF HNPCC (1998) (0)
EDITORIALS Prophylactic Mastectomy: Obstacles and Benefits (2001) (0)
Stemming the tide of cancer for BRCA1 (2008) (0)
Hereditary breast cancer: Shared communication and care. Authors' disclosures (2003) (0)
Ultimately, It Matters Where, When, and What They'll Meet (2008) (0)
Letter: Lay volunteers and mobile multiphasic cancer screening. (1974) (0)
EDITORIALS Microsatellite Instability, Clinical Implications, and New Methodologies (2000) (0)
The life and death of medical records. (1970) (0)
Mammography and hereditary breast cancer (2005) (0)
Hereditary Aspects of some Less Frequently Occurring Malignancies Exclusive of the Reticuloendothelial System (1967) (0)
Cáncer gástrico difuso hereditario: implicaciones para la oncología quirúrgica profiláctica (2008) (0)
Genetic predictability in certain forms of cancer. (1972) (0)
Title Novel MSH 2 Mutation in the First Report of a Vietnamese-American Kindred with Lynch Syndrome (2015) (0)
Heredity and colon cancer. Part III. Gardner's syndrome. (1975) (0)
Familial myeloma - Reply (2008) (0)
Table 2. [Biallelic Germline MUTYH Pathogenic Variant...]. (2015) (0)
Breast cancer,genetics, andageatfirst pregnancy (1984) (0)
Oncogenetics and Interdisciplinary Collaborations: Essential for Progress (2006) (0)
Hereditary breast and ovarian cancer: lessening the burden. (2013) (0)
Genetics and cancer control: identification of high risk patients (1973) (0)
Cancer resistance. II. Cancer variations in families in a normal population. (1974) (0)
Identification of new susceptibility genes in familial breast cancer by exome sequencing. (2012) (0)
Foreword for “100 years of Lynch syndrome” (2013) (0)
Thirty-nine-year-old with familial colon cancer, and variant of undetermined significance in MSH6. (2012) (0)
675 Unveiling of DNA Repair Gene Alterations in Non-Lynch Hereditary Colorectal Cancer Through Exome Sequencing (2014) (0)
750 Identification of Inherited Predisposition to Colonic Neoplasia Through Partial Wave Spectroscopic Analysis of the Microscopically Normal Colonic Epithelium (2008) (0)
Medical/Legal Concerns in the Management of Patients from Lynch Syndromes Kindreds (1990) (0)
BIOMARKERS AND COLORECTAL CANCER GENETICS: LYNCH SYNDROMES I AND II (1987) (0)
Environment and genes in the development of colorectal cancer. (1999) (0)
Cancer genetics: urological system. II. (1974) (0)
The flat adenoma: Significance and management (1993) (0)
Hereditary colorectal cancer and brain tumor syndromes (2006) (0)
Classical Examples of Heredity and Malignancy (1967) (0)
Rare diseases of the digestive system (2016) (0)
Cancer genetics, genetic counseling, and cancer control. Part II. (1975) (0)
Identification of BRCA1 and BRCA2 genetic modifiers. (2009) (0)
Skin, genetics, and cancer a trilogic approach to cancer control. (1971) (0)
Cellular Immune Response in Lynch Syndrome II on Gastrointestinal Biopsy (1990) (0)
Melanocytic dysplasia and internal malignancy (1987) (0)
CHAPTER 2 CLASSICAL EXAMPLES OF HEREDITY AND MALiGNANCY (1967) (0)
W1401 Dose-Dependent Effects of Alcohol and Tobacco On Age of Presentation in Pancreatic Cancer (PC): A Multicenter, International Study (2008) (0)
Hyperphosphorylation of Antigenic Targets of Paraproteins In MGUS and Multiple Myeloma (MM) Is a Consistent Finding: Implications for the Pathogenesis of MGUS/MM (2010) (0)
Cancer and you (1971) (0)
Primary choroidal andcutaneous melanomas, bilateral choroidal melanomas, andfamilial occurrenceof melanomas (1982) (0)
Contents Volume 4 (2005) (0)
Familial cancer syndromes (2016) (0)
Hereditary colorectal carcinoma syndromes and their implications for colorectal carcinoma in Puerto Rico. (1998) (0)
In Memoriam: Dr. Enrique Pimentel (1995) (0)
The Rubinstein et al Article Reviewed (2002) (0)
Recent Progress in Cancer Family Syndrome. (1970) (0)
Families Evaluable by Linkage (2007) (0)
Phenotypic variations in hereditary diseases with implications for genetic counseling: a family with congenital heart and skeletal anomalies. (1966) (0)
Genetics and cancer in children. (1978) (0)
Rare alleles of the HRAS polymorphism do not modify the risk of breast or ovarian cancer in BRCA1 carriers (1994) (0)
Heredity and Cancer Control: Genetic Counseling. (1967) (0)
Other Cancers with Familial Clusterings (2003) (0)
Hereditary Disorders with Variable Malignant Neoplastic Predisposition (1967) (0)
Mo1739 - Risk of Gastric Cancer in Lynch Syndrome Persists in U.S. Families (2018) (0)
Re: Familial multiple myeloma: A family study and review of the literature - Response (2002) (0)
The role of prophylactic surgery for hereditary breast and ovarian cancer (1997) (0)
Inherited, Familial andSporadic Primary Open-Angle Glaucoma (2007) (0)
FIS impact upon BRCA testing uptake and prophylactic oophorectomy/mastectomy among HBOC attendees (2008) (0)
Familial Cancer: Introduction (2005) (0)
Update in Cancer Genetics: Clinical translation - Foreword (2008) (0)
Family Chronicles of Missed Opportunities. (2016) (0)
GENETIC COUNSELING. (1964) (0)
Nonsteroidal Anti-Inflammatory Drugs (NSAID) and Colorectal Cancer (2004) (0)
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study (2015) (0)
Prevalence of PALB2 mutations in the Creighton University breast cancer family registry. (2015) (0)
Cancer genetics, part III: genetic markers, childhood cancer problems (1973) (0)
Genetic counseling (a scientific exhibit). (1970) (0)
Short stature and language delay in a 5-year-old girl: 18p- syndrome. (1982) (0)
Function Factor II Expression in Breast Stroma : Evidence for Paracrine Malignant Breast Epithelium Selects for Insulin-like Growth Updated (2006) (0)
Use of the Lectin from Amarant hus cautiat us as a Histochemical Probe of Proliferating Colonie Epithelial Cells 1 (2006) (0)
DNA screening for cancer susceptibility (1997) (0)
Table 4. [Selected MUTYH Pathogenic Allelic Variants]. (2015) (0)
Cancer genetics. II. Studies in humans. Problems in human studies. (1973) (0)
Volume Contents (2004) (0)
P0015 PP BETA CATENIN IMMUNOHISTOCHEMISTRY IN SYNDROMIC COMPARED TO SPORADIC JUVENILE POLYPS (2004) (0)
The Cutaneous Manifestations of the Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome (2019) (0)
Cancer and heredity: implications for early cancer detection. (1968) (0)
The long term impact of resistant starch on cancer risk in carriers of hereditary colorectal cancer:the CAPP2 Randomised Controlled Trial (2012) (0)
Southwestern Athabaskan genetic diseases. (1999) (0)
Familial pancreatic cancer: Insight into etiology or an interesting quirk of nature? (1990) (0)
Advances in Brief HMSH 2 Mutations in Hereditary Nonpolyposis Colorectal Cancer Kindreds 1 (2006) (0)
Riskandsurveillance ofindividuals withheritable factors forcolorectal cancer (1990) (0)
Abstract 2300: Deleterious germline mutations in theBRCA1gene are associated with increased risk for cancers of the female reproductive system other than breast and ovarian as well as other cancers (2020) (0)
Genetic Disorders Associated with Exocrine and Endocrine Pancreatic Tumors (2005) (0)
Cancer Genetics (1971) (0)
NATURE VS NURTURE; DISEASE EXPRESSION IN JUVENILE POLYPOSIS SYNDROME MAY BE INFLUENCED BY EXOGENOUS FACTORS AND COMORBID DISEASE: 137 (2005) (0)
Heredity and colon cancer. Part II. Polyposis coli syndromes. (1975) (0)
Familial Aggregation in Genetic Studies of Primary Open–Angle Glaucoma (2005) (0)
Brief report Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent ﬁnding in familial and sporadic MGUS/MM (2011) (0)
KLHDC8B Is a Novel, Mitotically-Regulated Classical Hodgkin’s Lymphoma Candidate Susceptibility Gene. (2006) (0)
Book Review The Third Conference on the Clinical Delineation of Birth Defects, Part X: The endocrine system: Held at Johns Hopkins Hospital, June 15–19, 1970. Edited by Daniel Bergsma, M.D. 330 pp., illustrated. Baltimore: Williams and Wilkins, 1971. $20.75. (1972) (0)
Psychodynamics in a Chronic Debilitating Hereditary Disease (2017) (0)
CHRPE in non-Gardner's familial polyposis coli patients. (1989) (0)
Heredity and colon cancer. Part IV. (1975) (0)
Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer (1999) (0)
Breast cancer and importance of zygosity determination in triplet sisters (2004) (0)
Abstract 1924: The paraproteins of patients with familial MGUS / multiple myeloma (MM) target family-specific antigens: Experience with paratarg-7 and paratarg-8 (2010) (0)
Congenital Cancer and Congenital Abnormalities Associated with Cancer (1967) (0)
Patients with Familial Adenomatous Polyposis and Identified APC Gene Mutations Associated with Turcotʼs Syndrome – Necessity of CNS Tumor Surveillance?: 515 (2006) (0)
Keratoacanthomas associated with cervical squamous cell carcinoma. (1985) (0)
Cancer genetics: strategies for preventive oncology. (1986) (0)
511e: Screening for Barrett'S in High Risk Families: Is It Worthwhile? (2010) (0)
Hereditary diffuse gastric cancer in the developing world: A Jordanian family. (2010) (0)
The Medical Bookshelf. (1982) (0)
Table 3. [Percentage of Persons with CRC...]. (2015) (0)
Abstract P3-08-08: Preferences for breast cancer risk reduction amongBRCA1andBRCA2mutation carriers: A discrete choice experiment (2017) (0)
Cancer genetics: urological system. Part I. (1974) (0)
Lynch Syndromes I and II - Natural History, Diagnosis and Control Strategies (1992) (0)
Clinical patterns and heredity of the FAMMM syndrome: 45 (1993) (0)
Incidence of early-onset multiple myeloma among families with endometrial carcinoma. (2010) (0)
Quality indicators for colonoscopy and the risk of interval cancer. (2010) (0)
Epidemiologic Linkage: Diet, Genetics, and Cancer (2018) (0)
Invited editorial (2000) (0)
Inherited Syndromes in Gastrointestinal Cancers (2010) (0)
Genetic Counseling Using BRCA1-Linked Markers (1996) (0)
Contents, Vol. 2, 1984 (1984) (0)
CHAPTER 1 HISTORY OF CANCER GENETICS IN MAN (1967) (0)
Lynch syndrome founder mutations in families of Navajo and German-American heritage. (2004) (0)
Hereditary Breast Cancer: Mutations Within BRCA1 and BRCA2 with Phenotypic Responses (2002) (0)
Integration of family history and medical management of patients with hereditary cancers (1999) (0)
Progress in clinical and research oncogenetics: Hereditary colon, breast, and pancreatic cancer (2003) (0)
Historical development of Lynch syndrome (2013) (0)
Complementation Group C and Malignant Melanoma (2017) (0)
Advances in Brief Genetic Instability of Microsatellites in Endometrial Carcinoma (2006) (0)
Cancer genetic. 3. Genetic markers, childhood cancer problems. (1973) (0)
Barrett’s esophagus in the patients with familial adenomatous polyposis (2013) (0)
CAPP2: a randomised chemoprevention trial of aspirin and resistant starch in Lynch Syndrome (2007) (0)
Case Novel MSH2 Mutation in the First Report of a Vietnamese – American Kindred with Lynch Syndrome Gynecologic (2015) (0)
Index of Books Reviewed (1978) (0)
Crypt Atrophy of Colorectal Mucosa in Lynch Syndromes I and II: Its Characteristics and Meaning, Preliminary Observations (1990) (0)
Detecting BRCA2 protein truncation in breast tissue biopsies to identify hereditary cancer. (2009) (0)
AN INTERNET BASED PEDIATRIC RESIDENT QUESTIONNAIRE ON KNOWLEDGE ON HEREDITARY GASTROINTESTINAL POLYPOSIS SYNDROMES: 135 (2005) (0)
The life and death of medical records. (1970) (0)
Invited editorial (1999) (0)
Vitamin D-Intoxicated Patient With (2016) (0)
Deletions Led to the Identification of Four New BRCA 1 Mutations in Screening for GermLine Rearrangements and Regulatory Updated Version (1999) (0)
Paramedical role in a multiphasic mobile cancer screening unit (1973) (0)
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer (2014) (0)
APC GENE MUTATIONS ASSOCIATED WITH TURCOT'S SYNDROME IN CHILDREN WITH FAMILIAL ADENOMATOUS POLYPOSIS: OPPORTUNITIES FOR TUMOR SURVEILLANCE? (2006) (0)
Screening for colorectal cancer: ask about the family (1979) (0)
Commentary: The shifting role of family history in Lynch syndrome diagnosis (2009) (0)
The History of Lynch Syndrome (2013) (0)
Introduction to special issue of Familial Cancer (2016) (0)
Medical genetics, Huntington's chorea, and legal questions pertaining to autopsy. (1983) (0)
Pancreatic cancer risk in BRCA2 mutation carriers extends beyond first degree relatives (2013) (0)
Concordant and discordant cancers in familial atypical multiple mole melanoma syndrome (FAMMM) with the CDKN2A mutation (2018) (0)
Prostate Cancer Genetics in African Americans (2014) (0)
Invited commentary (2005) (0)
Determining familial risk of multiple myeloma (2007) (0)
Effect of hierarchical clustered sampling in multicenter, family-based studies: Example of reproductive history and breast cancer risk in BRCA1 mutation carriers. (2000) (0)
Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge (2017) (0)
Lifetime Colonic Polyp Rate Comparisons and the EPCAM Deletion (2015) (0)
History of Cancer Genetics in Man (1967) (0)
Accurate classification of MLH1 (2008) (0)
Colonoscopy Findings in a Series of Patients with Hereditary Colorectal Cancer (1990) (0)
Iatrogenic hypothyroidism in a patient with Turner's syndrome. (1965) (0)
Molecular screening, genetic counseling, and cancer prevention: Lynch syndrome as a model (2012) (0)
Attenuated familial adenomatous polyposis: association of age and polyp characteristics with colorectal cancer (1998) (0)
Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry (2015) (0)
Report on a Pair of Male Monozygotic Twins Concordant for Schizophrenia (1972) (0)
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation (2019) (0)
Author reply (0)
Genetic counseling. (1972) (0)
Erratum to: A new hereditary colorectal cancer network in the Middle East and eastern Mediterranean countries to improve care for high-risk families (2018) (0)
Penetrating the information maze. (1983) (0)
Prophylactic cranial irradiation: going, going, gone (2009) (0)
Precursors to Malignant Melanoma-Reply (1985) (0)
Colorectal Cancer: From Pathogenesis to Prevention (1989) (0)
Impact of BRCA mutation test results in members of hereditary breast ovarian cancer (HBOC) families (2005) (0)
Table 1. [Molecular Genetic Testing Used in MUTYH-Associated Polyposis]. (2015) (0)
Cancer genetics. I. Historical background and animal studies. (1973) (0)
My specialty: cancer genetics. (1979) (0)
Familial Breast and Colorectal Cancer (1990) (0)
Familial prostate cancer and HOXB13 founder mutations: geographic and racial/ethnic variations (2012) (0)
New Series to Explore Cancer Genetic Issues (1997) (0)
184 – Cancer Genetics (2012) (0)
Genetics and medical emergencies: an interesting patient. (1982) (0)
Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity (2016) (0)
Erratum: Smoking and the risk of breast cancer among carriers of BRCA mutations (International Journal of Cancer (2004) 110 (413-416)) (2005) (0)
Epidemiology and Carcinogenesis of Rectal Cancer (2018) (0)
Regression of colorectal adenomas with intravenous chemotherapy in a patient with familial adenomatous polyposis. (2004) (0)
Teaching comprehensive medicine in the home setting: a preliminary report. I. (1969) (0)
Subject Index, Vol. 2, 1984 (1984) (0)
A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families (2017) (0)
Clinicopathologic and Genetic Studies of the Lynch Syndromes and Familial Nonpolyposis Colorectal Cancer: An Update with Screening Recommendations1 (1991) (0)
Lynch syndrome in South America: past, present and future (2016) (0)
News and notices (2005) (0)

This paper list is powered by the following services:

Other Resources About Henry T. Lynch

en.wikipedia.org

What Schools Are Affiliated With Henry T. Lynch?

Henry T. Lynch is affiliated with the following schools:

Henry T. Lynch's Academic­Influence.com Rankings